Collaboration extension
It has been revealed that the collaboration between Thermo Fisher Scientific?s Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center and three organizations will be extended.
It has been revealed that the collaboration between Thermo Fisher Scientific’s Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center and three organizations will be extended.
Over the last couple of years, the BRIMS Center, George Mason University’s Center for Applied Proteomics and Molecular Medicine (CAPMM), Johns Hopkins University and Toronto’s University Health Network (UHN) have collaborated to speed up protein biomarker identification for cancer and other diseases. The results of this collaboration were recently demonstrated at the US Human Proteome Organization 2010 meeting in Denver, Colorado, USA.
To address the challenges set out by biomarker researchers seeking to independently validate hypothetical biomarkers and routine mass spectrometry-based quantitative assays suited for clinical research, the BRIMS Center developed targeted SRM-based quantitative mass spectrometry workflows that allow rapid assay development and cross validation of biomarker assays across the network of laboratories. Each of the collaborators uses these biomarkers and assays to perform research on identical Thermo Scientific TSQ Quantum Ultra triple quadrupole mass spectrometry platforms.
The director of the BRIMS Center, Mary Lopez, stated, “Working together, the BRIMS Center and the collaborators demonstrated an instrument platform and an end-to-end workflow from sample preparation through data analysis that are easily and reproducibly transferred from laboratory to laboratory. By continuing our work with these leading research groups, we can extend their ground-breaking research by continuing to apply the SRM-based workflow to previously validated clinical biomarkers.”
This study is reportedly the first inter-lab study to demonstrate reproducible determination of protein abundance in a complex matrix such as blood.
For more information visit Thermo’s website at www.thermo.com/proteomics
This story originally appeared in The Column. Click here to view that issue.
SPME GC-MS–Based Metabolomics to Determine Metabolite Profiles of Coffee
November 14th 2024Using a solid phase microextraction gas chromatography-mass spectrometry (SPME GC-MS)-based metabolomics approach, a recent study by the School of Life Sciences and Technology at Institut Teknologi Bandung (Indonesia) investigated the impact of environmental factors (including temperature, rainfall, and altitude) on volatile metabolite profiles of Robusta green coffee beans from West Java.
RP-HPLC Analysis of Polyphenols and Antioxidants in Dark Chocolate
November 13th 2024A recent study set out to assess the significance of geographical and varietal factors in the content of alkaloids, phenolic compounds, and the antioxidant capacity of chocolate samples. Filtered extracts were analyzed by reversed-phase high-performance liquid chromatography (RP-HPLC) with ultraviolet (UV) and spectrophotometric methods to determine individual phenolics and overall indexes of antioxidant and flavonoid content.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Katelynn Perrault Uptmor Receives the 2025 LCGC Emerging Leader in Chromatography Award
Published: November 13th 2024 | Updated: November 13th 2024November 13, 2024 – LCGC International magazine has named Katelynn A. Perrault Uptmor, Assistant Professor of Chemistry at the College of William & Mary, the recipient of the 2025 Emerging Leader in Chromatography Award. This accolade, which highlights exceptional achievements by early-career scientists, celebrates Perrault Uptmor’s pioneering work in chromatography, particularly in the fields of forensic science, odor analysis, and complex volatile organic compounds (VOCs) research.
